Approval · Notice of Compliance 17769 · 2016
KEXXTONE: Notice of Compliance 17769
Issued February 12, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17769
- Date
- February 12, 2016
- Company
- Elanco Division Eli Lilly Canada IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antibiotic, antiketogenic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KEXXTONE | 02451999 | Marketed |
Medicinal ingredients
- MONENSIN SODIUM 35.16 G per CAP